AVADEL PHARMACEUTICALS PLC — Director's Dealing 2016

Dec 20, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLAMEL TECHNOLOGIES SA (FLML)
CIK: 0001012477
Period of Report: 2016-12-19

Reporting Person: STAPLETON CRAIG R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-19	ADSs	G	5400	—	Disposed	514278	Direct
2016-12-19	ADSs	G	8100	—	Disposed	506178	Direct
2016-12-19	ADSs	G	13500	—	Disposed	492678	Direct
2016-12-19	ADSs	G	5400	—	Disposed	34600	Indirect
2016-12-19	ADSs	G	8100	—	Disposed	26500	Indirect
2016-12-19	ADSs	G	13500	—	Acquired	40000	Indirect
2016-12-19	ADSs	G	16200	—	Acquired	16200	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants (right to buy)	$14.54	2018-06-24	ADSs (100000)	100000	Direct
Warrants (right to buy)	$14.54	2018-06-24	ADSs (117449)	117449	Direct

Footnotes

F1: The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value 0.122 Euros per share, of the issuer; ADSs are represented by American Depositary Receipts.

F2: Reflects the transfer of securities by the reporting person to his children.

F3: Reflects the transfer of securities by the reporting person to a family trust.

F4: Reflects the transfer of securities by the reporting person to his spouse.

F5: Reflects the transfer of securities by the reporting person's spouse to children of the reporting person.

F6: The filing of this statement shall not be construed as an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of these securities.

F7: Reflects the transfer of securities by the reporting person's spouse to a family trust.

F8: Reflects the acquisition by the reporting person's spouse of securities transferred from the reporting person.

F9: Reflects the acquisition by a family trust of securities transferred from the reporting person and his spouse.

F10: Warrants were granted 06/24/2014 but were not exercisable until the first anniversary of the date of grant; on such first anniversary the warrants became exercisable for a 3-year period as to all 100,000 ADSs. The warrant exercise price per ADS may be paid in U.S. Dollars as shown in Item 4 of Table II or in Euros based on the exchange rate prevailing on the date of grant, or (euro)10.94 per ADS.

F11: Warrants were granted 06/26/2015 but are not exercisable until the first anniversary of the date of grant; on such first anniversary the warrants will become exercisable for a 3-year period as to all 117,449 ADSs. The warrant exercise price per ADS may be paid in U.S. Dollars as shown in Item 4 of Table II or in Euros based on the exchange rate prevailing on the date of grant, or (euro)19.34 per ADS. Warrants as to all 117,449 ADSs vest on 06/26/2016.